Nationwide multicenter study of advanced endoscopic resection and malignant risk model for gastric myogenic tumors (GASTRO Trial)

This study confirms that endoscopic resection is a safe and effective treatment for gastric myogenic tumors, boasting an impressive 97% success rate. Researchers identified age, fundus location, and specific ultrasound features as independent risk factors for gastrointestinal stromal tumors. A new prediction model helps clinicians accurately assess malignant potential, enabling these minimally invasive techniques to replace traditional surgery.